|Bid||43.71 x 900|
|Ask||44.24 x 900|
|Day's range||41.13 - 44.73|
|52-week range||40.49 - 107.79|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||93.89|
|Earnings date||08 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||71.36|
In the latest trading session, Doximity (DOCS) closed at $43.32, marking a +1.14% move from the previous day.
Doximity (NYSE: DOCS) is the most popular digital platform among U.S. healthcare professionals. In this Backstage Pass video recorded on Jan. 4, 2022, Motley Fool contributor Jamie Louko explains why Doximity looks like a smart long-term investment. Jamie Louko: My pick is Doximity.
Shares of doctor-focused social networking company Doximity (NASDAQ: DOCS) plunged 26% in December, according to data provided by S&P Global Market Intelligence. There wasn't any specific news this month leading to the decline, but it follows months of a price decrease as the stock ballooned after its initial public offering (IPO) in June and its valuation skyrocketed. Doximity operates a digital networking platform for physicians.